Shingles of the eye: NYU leads multi-center clinical trial for new treatment
by Press Release from Outbreak News Today on (#22KX9)
NYU Langone Medical Center will lead a 5-year, 60-center clinical trial to evaluate new treatment protocols for herpes zoster ophthalmicus (HZO), a form of shingles that can seriously and permanently affect the eye. The project is being funded through a $15 million grant from the National Eye Institute, a division of the National Institutes of ["]
The post Shingles of the eye: NYU leads multi-center clinical trial for new treatment appeared first on Outbreak News Today.